speb/financial-data huggingface dataset:
Stock screener scorecard for HDFCAMC.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 4.110402405152076%
Rule of 40 score: 4.110402405152076
Market cap: 1074411012096 (Mega Cap (>= $200B))
P/E ratio: 0.40766522480112793
Debt to equity: 0.0236
Operating income: 87551429.47568308
Net income: 88314168.16119844
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HQL (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 585354944 (Small Cap ($300M-$2B))
P/E ratio: 2.371987951807229
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IDIP.PA (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.201602137998321%
Capitalized R&D asset: 0
Free cash flow margin: -45.59959161951103%
Revenue growth: 121.82748594883479%
Rule of 40 score: 76.22789432932376
Market cap: 513688672 (Small Cap ($300M-$2B))
P/E ratio: 9.400384095597126
Debt to equity: 0.0412
Free cash flow (dilution adjusted): -49392941.17647059
Net income: 69425882.35294119
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IDIP.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 513688672 (Small Cap ($300M-$2B))
P/E ratio: 9.400384095597126
Debt to equity: 0.0412
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IDX.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 764786368 (Small Cap ($300M-$2B))
P/E ratio: 40.35947712418301
Debt to equity: 0.8822
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for IGC (quarterly, report date 2026-03-31)
Altman Z-score: -15.080823692704785 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -274.9120750293083%
Capitalized R&D asset: 2788980
ROCI (R&D adjusted): -28.934612902493278%
Rosenberg metric: 0.007422402159244264
Free cash flow margin: -757.7287066246057%
Revenue growth: -9.428571428571429%
Rule of 40 score: -767.1572780531772
Market cap: 27552668 (Nano Cap (< $50M))
Debt to equity: 0.15130000000000002
Free cash flow (dilution adjusted): -2402000
Operating income: -2458000
Net income: -2402000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for KLR.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2246634496 (Mid Cap ($2B-$10B))
P/E ratio: 0.11062067092217846
Debt to equity: 0.4818
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LIMN (quarterly, report date 2026-03-31)
Altman Z-score: -19.888376390834413 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 400000
ROCI (R&D adjusted): -277.31357440292174%
Rule of 40 score: 0
Market cap: 7448084 (Nano Cap (< $50M))
Debt to equity: -10.878910374370268
Free cash flow (dilution adjusted): -2015289
Operating income: -1100898
Net income: -1123714
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for LUCE.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 369447520 (Small Cap ($300M-$2B))
P/E ratio: 0.13409563409563408
Debt to equity: 0.6131
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LZM (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 290957696 (Micro Cap ($50M-$300M))
Debt to equity: 0.7312000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LZM (annual, report date 2025-12-31)
Altman Z-score: -3.0327167587106407 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -46.55363607004933%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.940209281144025%
Free cash flow margin: -3854.568830217882%
Revenue growth: 713.217282126065%
Rule of 40 score: -3141.3515480918168
Market cap: 290957696 (Micro Cap ($50M-$300M))
Debt to equity: 0.7312000000000001
Free cash flow (dilution adjusted): -55060067.56756757
Operating income: -25131955.405405406
Net income: -18416048.64864865
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MEDP (quarterly, report date 2026-06-30)
Altman Z-score: 6.210831257055881 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -39.810047965755125%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.614560146167605%
Free cash flow margin: 18.909393197809795%
Revenue growth: 0.10288648238617386%
Rule of 40 score: 19.01227968019597
Market cap: 16785511424 (Large Cap ($10B-$200B))
P/E ratio: 31.115746180963576
Debt to equity: 0.3322
Free cash flow (dilution adjusted): 133752000
Operating income: 146824000
Net income: 121362000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for MEHA (quarterly, report date 2026-03-31)
Altman Z-score: -2.707740391473697 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -15.603005590350522%
Free cash flow margin: -33.29316375817065%
Revenue growth: 10.103772379243917%
Rule of 40 score: -23.189391378926732
Market cap: 194149 (Nano Cap (< $50M))
Debt to equity: -0.7211255122192161
Free cash flow (dilution adjusted): -547847
Operating income: -682805
Net income: -6990789
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for MLHCF.PA (annual, report date 2024-12-31)
Altman Z-score: 1.8070382165805114 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.19274839879822486%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.487370723634285%
Revenue growth: -45.35454363137698%
Rule of 40 score: -45.35454363137698
Market cap: 15229040 (Nano Cap (< $50M))
Debt to equity: 1.454948688968881
Operating income: 876450
Net income: -46665.625
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MODE.L (annual, report date 2025-12-31)
Altman Z-score: -487.2348572916665 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -100.36057692307693%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1074111 (Nano Cap (< $50M))
P/E ratio: 0.013513513513513514
Debt to equity: -0.6243990384615384
Free cash flow (dilution adjusted): -82432.43243243244
Operating income: -360810.8108108108
Net income: 2256756.756756757
Long score: 1 | Short score: 11
Recommendation: Short
Stock screener scorecard for MODE.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1074111 (Nano Cap (< $50M))
P/E ratio: 0.013513513513513514
Debt to equity: -0.6243990384615384
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MXO.AX (annual, report date 2025-06-30)
Altman Z-score: 1.4389958308192883 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 48.11848611837343%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.9969911365849837%
Free cash flow margin: 12.898028243753162%
Revenue growth: 9.871575627803281%
Rule of 40 score: 22.76960387155644
Market cap: 15831107 (Nano Cap (< $50M))
P/E ratio: 109.00901378871082
Debt to equity: 0.030699999999999998
Free cash flow (dilution adjusted): 790507.8431372549
Operating income: 107079.08496732026
Net income: 75935.9477124183
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for MXO.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15831107 (Nano Cap (< $50M))
Debt to equity: 0.030699999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NAVA.OL (annual, report date 2025-12-31)
Altman Z-score: 1.5636372946032062 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.9339990108696044%
Free cash flow margin: 4.104294793219884%
Revenue growth: 19.932583112182765%
Rule of 40 score: 24.036877905402648
Market cap: 400489024 (Small Cap ($300M-$2B))
Debt to equity: 0.6543000000000001
Free cash flow (dilution adjusted): 2308855.721393035
Operating income: 1617412.935323383
Net income: -2342089.5522388057
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NDLVENTURE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 44.10180684051415 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.2558580013391645%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.7706016724864901%
Rule of 40 score: 0
Market cap: 4210972672 (Mid Cap ($2B-$10B))
P/E ratio: 4.40870587526
Debt to equity: 0
Operating income: -111880.03391267486
Net income: 16076.727426875796
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for NDLVENTURE.NS (annual, report date 2026-03-31)
Altman Z-score: 43.96937024749295 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.5353166685500426%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.15609873909412%
Rule of 40 score: 0
Market cap: 4210972672 (Mid Cap ($2B-$10B))
P/E ratio: 4.40870587526
Debt to equity: 0
Free cash flow (dilution adjusted): -496492.1576939381
Operating income: -388988.9783806698
Net income: 96470.96227214922
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for NOBL.V (quarterly, report date 2026-03-31)
Altman Z-score: 31.344950140380515 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -29.286733233222513%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.761226215926888%
Rule of 40 score: 0
Market cap: 9340297 (Nano Cap (< $50M))
Debt to equity: 0.006999999999999999
Free cash flow (dilution adjusted): -593451.7985611511
Operating income: -200012.23021582735
Net income: -200128.77697841727
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for PGH.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 124449832 (Micro Cap ($50M-$300M))
P/E ratio: 0.18427518427518427
Debt to equity: 0.0123
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PGH.L (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 35.13999308676115%
Capitalized R&D asset: 0
Free cash flow margin: 13.196723002950947%
Revenue growth: 19.58844045040315%
Rule of 40 score: 32.7851634533541
Market cap: 124449832 (Micro Cap ($50M-$300M))
P/E ratio: 0.18427518427518427
Debt to equity: 0.0123
Free cash flow (dilution adjusted): 8641891.891891891
Net income: 9845945.945945946
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for PXS.L (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 28033402 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for REM.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 11634.369845474614
Rule of 40 score: 0
Market cap: 6062428 (Nano Cap (< $50M))
Debt to equity: 0.3005
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for RENE.LS (quarterly, report date 2026-03-31)
Altman Z-score: 0.4278465507498914 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.620408779335148%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.7140620631292396%
Free cash flow margin: 31.82797584168831%
Revenue growth: -30.80165738163495%
Rule of 40 score: 1.0263184600533606
Market cap: 2440980480 (Mid Cap ($2B-$10B))
P/E ratio: 14.427269124058661
Debt to equity: 1.5406
Free cash flow (dilution adjusted): 79290804.59770115
Operating income: 84417241.37931034
Net income: 41621839.08045977
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SDHY (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 392301568 (Small Cap ($300M-$2B))
P/E ratio: 13.283333333333333
Debt to equity: 0.229223601415806
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SDI.L (quarterly, report date 2025-10-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 98298736 (Micro Cap ($50M-$300M))
P/E ratio: 0.2763157894736842
Debt to equity: 0.5067
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SIFG.AS (annual, report date 2025-12-31)
Altman Z-score: 0.6621347227797774 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1747961.5196078431
ROCI (R&D adjusted): -10.329044333493771%
Rosenberg metric: 19.050755384120862
Free cash flow margin: 0.7574044576652447%
Revenue growth: 57.18345386925024%
Rule of 40 score: 57.94085832691549
Market cap: 127773816 (Micro Cap ($50M-$300M))
Debt to equity: 1.1689
Free cash flow (dilution adjusted): 5320000
Operating income: -48820000
Net income: -40563529.4117647
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SIFG.AS (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 127773816 (Micro Cap ($50M-$300M))
Debt to equity: 1.1689
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SNT (quarterly, report date 2026-03-31)
Altman Z-score: 3.2457446816228024 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.6791368179004165%
Capitalized R&D asset: 1305236.569868193
ROCI (R&D adjusted): -0.9225296573316383%
Rosenberg metric: -0.8325676415389424
Revenue growth: -9.169135280011268%
Rule of 40 score: -9.169135280011268
Market cap: 41063708 (Nano Cap (< $50M))
P/E ratio: 50.5
Debt to equity: 0.0131
Operating income: -434532.37410071946
Net income: -598561.1510791368
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for SRV (quarterly, report date 2025-11-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 231933488 (Micro Cap ($50M-$300M))
P/E ratio: 333.8181818181818
Debt to equity: 0.273942555858046
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SRV (annual, report date 2025-11-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.9401744422020208%
Capitalized R&D asset: 0
Free cash flow margin: -201.72071082739654%
Revenue growth: -67.83134775711981%
Rule of 40 score: -269.5520585845164
Market cap: 231933488 (Micro Cap ($50M-$300M))
P/E ratio: 333.8181818181818
Debt to equity: 0.273942555858046
Free cash flow (dilution adjusted): -10018447
Net income: 3917637
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for TNIE.DE (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1579833600 (Small Cap ($300M-$2B))
P/E ratio: 122.8235294117647
Debt to equity: 0.1033
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TRMED.OL (annual, report date 2025-12-31)
Altman Z-score: 3.282048631923406 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -57.45568300312826%
Capitalized R&D asset: 226311.44171029155
ROCI (R&D adjusted): -10.640300864041993%
Free cash flow margin: -31150%
Rule of 40 score: -31150
Market cap: 1508407680 (Small Cap ($300M-$2B))
Debt to equity: 0.37579999999999997
Free cash flow (dilution adjusted): -12398009.950248756
Operating income: -6935323.383084577
Net income: -5771144.278606965
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for TRMED.OL (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1508407680 (Small Cap ($300M-$2B))
Debt to equity: 0.37579999999999997
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for XEL (quarterly, report date 2026-03-31)
Altman Z-score: 0.707356716086235 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.023439469041418%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.9482847963519536%
Free cash flow margin: -33.225565779656804%
Revenue growth: 12.917719741645605%
Rule of 40 score: -20.3078460380112
Market cap: 50984095744 (Large Cap ($10B-$200B))
P/E ratio: 22.464387464387464
Debt to equity: 1.6484999999999999
Free cash flow (dilution adjusted): -1336000000
Operating income: 732000000
Net income: 556000000
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 3893.HK (annual, report date 2025-06-30)
Altman Z-score: -3.556807049753863 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -24.24154920680756%
Revenue growth: -25.31375926827056%
Rule of 40 score: -49.55530847507812
Market cap: 149357236.35 (Micro Cap ($50M-$300M))
Debt to equity: -1.3458692408416824
Free cash flow (dilution adjusted): -1711082.8025477708
Operating income: -1601019.1082802548
Net income: -3593757.96178344
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 4174.T (annual, report date 2026-01-31)
Altman Z-score: 2.49284526172569 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.607106533864%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.906885382750795%
Free cash flow margin: -0.5255742573282762%
Revenue growth: 11.18343942595859%
Rule of 40 score: 10.657865168630313
Market cap: 2662637795.9999995 (Mid Cap ($2B-$10B))
Debt to equity: 1.006796242773013
Free cash flow (dilution adjusted): -341616.6100809611
Operating income: -2020063.9853747715
Net income: -3038208.4095063987
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for 480A.T (annual, report date 2025-12-31)
Altman Z-score: 8.336817201888229 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 21.344389847901464%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.664413897413276%
Free cash flow margin: 9.651597493430838%
Revenue growth: 23.207385285901466%
Rule of 40 score: 32.85898277933231
Market cap: 8663906913.018396 (Mid Cap ($2B-$10B))
P/E ratio: 16.95550485052888
Debt to equity: 0
Free cash flow (dilution adjusted): 3769822.901349019
Operating income: 5365162.0740361875
Net income: 3266920.273639793
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6535.T (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 34042636914 (Large Cap ($10B-$200B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9313.T (annual, report date 2025-11-30)
Altman Z-score: 1.340547934850096 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.534312958831054%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.629289638588462%
Free cash flow margin: -51.11567135575545%
Revenue growth: -4.440300626016888%
Rule of 40 score: -55.55597198177234
Market cap: 5956720158 (Mid Cap ($2B-$10B))
P/E ratio: 19.078354508301736
Debt to equity: 0.42961430989218835
Free cash flow (dilution adjusted): -16128263.373432301
Operating income: 3182134.630151011
Net income: 1997850.0127975428
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AUMN.TO (annual, report date 2025-12-31)
Altman Z-score: -349.8394419962377 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 307.06018518518516%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -410.300925925926%
Rule of 40 score: 0
Market cap: 4645459.970802919 (Nano Cap (< $50M))
P/E ratio: 1.7510214741058874
Debt to equity: 0
Free cash flow (dilution adjusted): -3994000
Operating income: -3545000
Net income: 2653000
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BARC.L (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.230215827338128%
Capitalized R&D asset: 0
Free cash flow margin: 57.927247769389155%
Revenue growth: 20.101802145263832%
Rule of 40 score: 78.02904991465299
Market cap: 633875448.2550001 (Small Cap ($300M-$2B))
P/E ratio: 0.08787958522875365
Debt to equity: 2.811250575182783
Free cash flow (dilution adjusted): 22810810810.81081
Net income: 9747297297.297297
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BRLS (annual, report date 2025-12-31)
Altman Z-score: -3.9354756433990876 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -22.59384943804775%
Revenue growth: 12.89924818169728%
Rule of 40 score: -9.694601256350472
Market cap: 58809458.440000005 (Micro Cap ($50M-$300M))
Debt to equity: -1.4082732367971915
Free cash flow (dilution adjusted): -5190916.788321168
Operating income: -8055463.503649634
Net income: -13853005.839416057
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for DTST (annual, report date 2025-12-31)
Altman Z-score: 3.9707042597491164 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 46.92841321055264%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.716814710800193%
Free cash flow margin: -302.5620259608411%
Revenue growth: 13.424843366438466%
Rule of 40 score: -289.1371825944026
Market cap: 11969218.56 (Nano Cap (< $50M))
P/E ratio: 0.6229111888190498
Debt to equity: 0
Free cash flow (dilution adjusted): -4184218
Operating income: -3573702
Net income: 19214968
Long score: 6 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for FSEA (annual, report date 2025-12-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.0197176892693596%
Capitalized R&D asset: 0
Free cash flow margin: -5.164503866823962%
Revenue growth: 16.01277372262774%
Rule of 40 score: 10.848269855803776
Market cap: 61930096.8 (Micro Cap ($50M-$300M))
Debt to equity: 0.823138779171322
Free cash flow (dilution adjusted): -788000
Net income: -845000
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GPUS.V (annual, report date 2025-09-30)
Altman Z-score: 2.6963226602007597 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -161.3106908557682%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -165.51304416815157%
Free cash flow margin: -1264.7575484395236%
Rule of 40 score: -1264.7575484395236
Market cap: 22928954.099999998 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -2866468.3453237414
Operating income: -5222982.01438849
Net income: -5054400
Long score: 3 | Short score: 14
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for HQL (annual, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.66375064214676%
Capitalized R&D asset: 0
Free cash flow margin: 36.70568463825684%
Revenue growth: -0.34528488878670566%
Rule of 40 score: 36.36039974947013
Market cap: 428753462.7 (Small Cap ($300M-$2B))
P/E ratio: 5.009132994602237
Debt to equity: 0
Free cash flow (dilution adjusted): 31708543
Net income: 85594346
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IGC (annual, report date 2025-03-31)
Altman Z-score: -14.647615850213837 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -150.4019651630192%
Capitalized R&D asset: 7325040
ROCI (R&D adjusted): -53.71440594212298%
Rosenberg metric: -0.030214683275907765
Free cash flow margin: -437.9228953579858%
Revenue growth: -5.5018587360594795%
Rule of 40 score: -443.4247540940453
Market cap: 29222527.6 (Nano Cap (< $50M))
Debt to equity: 0.03759873617693523
Free cash flow (dilution adjusted): -5566000
Operating income: -7446000
Net income: -7121000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for JPM.TO (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 22.10517484394926%
Capitalized R&D asset: 0
Free cash flow margin: -81.2672191457654%
Revenue growth: 12.023266302197849%
Rule of 40 score: -69.24395284356754
Market cap: 1128500492372.99 (Mega Cap (>= $200B))
P/E ratio: 19.781596065996883
Debt to equity: 1.379496631147946
Free cash flow (dilution adjusted): -107870072992.70071
Net income: 41640875912.40875
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LIMN (annual, report date 2025-12-31)
Altman Z-score: -145.77148886668087 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3038983.7800000003
Rule of 40 score: 0
Market cap: 40967820.82 (Nano Cap (< $50M))
Debt to equity: -0.14697356717328822
Free cash flow (dilution adjusted): -9976426
Operating income: -2967812
Net income: -10206517
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MEDP (annual, report date 2025-12-31)
Altman Z-score: 7.8361406849082 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -189.1871000443515%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 84.67859381628686%
Free cash flow margin: 25.57395877219261%
Revenue growth: 19.970090855900324%
Rule of 40 score: 45.544049628092935
Market cap: 15676581030.75 (Large Cap ($10B-$200B))
P/E ratio: 34.75012586534049
Debt to equity: 0.2475499432549649
Free cash flow (dilution adjusted): 647081000
Operating income: 534935000
Net income: 451123000
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for MEHA (annual, report date 2025-12-31)
Altman Z-score: -0.29214457144722705 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -170.4478811780742%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -41.646254054977966%
Free cash flow margin: -27.57512534251009%
Revenue growth: 0.685742916078767%
Rule of 40 score: -26.889382426431325
Market cap: 8019220.18 (Nano Cap (< $50M))
P/E ratio: 10.572778880864046
Debt to equity: 1.7284768813447597
Free cash flow (dilution adjusted): -1823125
Operating income: -1398572
Net income: 758478
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for NAVA.OL (quarterly, report date 2025-06-30)
Altman Z-score: 1.69611336539212 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.9725937784039982%
Free cash flow margin: 0.2724418511476795%
Revenue growth: 17.727419542213017%
Rule of 40 score: 17.999861393360696
Market cap: 551571694 (Small Cap ($300M-$2B))
Debt to equity: 0.6154798132558773
Free cash flow (dilution adjusted): 37140.01986097319
Operating income: 622840.1191658392
Net income: -152234.35948361468
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NOBL.V (annual, report date 2025-09-30)
Altman Z-score: 23.866509042537807 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -114.39114509035902%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -48.903359888051654%
Rule of 40 score: 0
Market cap: 12453729.28 (Nano Cap (< $50M))
Debt to equity: 0.09910096277493878
Free cash flow (dilution adjusted): -991255.3956834533
Operating income: -440484.17266187054
Net income: -477281.2949640288
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for PXS.L (annual, report date 2025-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -34.88999386542783%
Capitalized R&D asset: 775426.0131087853
ROCI (R&D adjusted): -29.986506996956493%
Rosenberg metric: 0.8716222131717192
Free cash flow margin: -39.40014424520446%
Revenue growth: 65.32023622267076%
Rule of 40 score: 25.9200919774663
Market cap: 0 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -661228.5714285714
Operating income: -586975.3246753246
Net income: -587948.0519480519
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for RENE.LS (annual, report date 2025-12-31)
Altman Z-score: 0.5295812111275493 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -13.765682742706018%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.148851922820248%
Free cash flow margin: 15.614530618649718%
Revenue growth: 21.031931526045863%
Rule of 40 score: 36.64646214469558
Market cap: 2076159949.4399996 (Mid Cap ($2B-$10B))
P/E ratio: 12.99118312928235
Debt to equity: 1.6555404301660765
Free cash flow (dilution adjusted): 187308235.29411766
Operating income: 282917647.0588235
Net income: 188015294.11764705
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SDHY (annual, report date 2025-07-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.496670050704969%
Capitalized R&D asset: 0
Free cash flow margin: 410.066996723803%
Revenue growth: -7.938810421980732%
Rule of 40 score: 402.12818630182227
Market cap: 382925829.12 (Small Cap ($300M-$2B))
P/E ratio: 10.253943488488856
Debt to equity: 0
Free cash flow (dilution adjusted): 154946189
Net income: 37344250
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for SNT (annual, report date 2025-12-31)
Altman Z-score: 9.532796533513622 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.34632571996028%
Capitalized R&D asset: 5389919.746312082
ROCI (R&D adjusted): 4.773585874821857%
Rosenberg metric: 0.4731284520307304
Free cash flow margin: 1.6055424204101831%
Revenue growth: 6.192548591195744%
Rule of 40 score: 7.798091011605927
Market cap: 154387881.0663 (Micro Cap ($50M-$300M))
P/E ratio: 47.99125926835561
Debt to equity: 0.012911884487226953
Free cash flow (dilution adjusted): 426277.3722627737
Operating income: 2197080.291970803
Net income: 2348175.182481752
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for XEL (annual, report date 2025-12-31)
Altman Z-score: 0.8967202507902104 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -24.600787835147614%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.8757707116125037%
Free cash flow margin: -46.84027541073011%
Revenue growth: 9.136224983260174%
Rule of 40 score: -37.70405042746994
Market cap: 45428095881.2 (Large Cap ($10B-$200B))
P/E ratio: 22.511444936174428
Debt to equity: 1.4732093693083146
Free cash flow (dilution adjusted): -6871000000
Operating income: 2879000000
Net income: 2018000000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 0352.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 88626024 (Micro Cap ($50M-$300M))
P/E ratio: 0.7712082262210798
Debt to equity: 1.2618
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0352.HK (annual, report date 2025-12-31)
Altman Z-score: 0.3929565524635215 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 82.08148919552201%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 34.7033428621434%
Free cash flow margin: -13.441307432597737%
Revenue growth: 1478.731216931217%
Rule of 40 score: 1465.2899094986192
Market cap: 88626024 (Micro Cap ($50M-$300M))
P/E ratio: 0.7712082262210798
Debt to equity: 1.2618
Free cash flow (dilution adjusted): -392428.5714285714
Operating income: 1699571.4285714286
Net income: 1691000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0488.HK (quarterly, report date 2026-01-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 988263552 (Small Cap ($300M-$2B))
Debt to equity: 0.9262999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1260.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 483610656 (Small Cap ($300M-$2B))
P/E ratio: 0.789570326845391
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1317.HK (quarterly, report date 2026-02-28)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 507525312 (Small Cap ($300M-$2B))
P/E ratio: 0.3410059676044331
Debt to equity: 1.6699000000000002
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1710.HK (annual, report date 2025-12-31)
Altman Z-score: 2.932574099617701 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.8467375967661983%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.467958271236959%
Free cash flow margin: 0.14304915266917595%
Revenue growth: -23.252554591289957%
Rule of 40 score: -23.109505438620783
Market cap: 475000000 (Small Cap ($300M-$2B))
Debt to equity: 0.3936
Free cash flow (dilution adjusted): 142544.98714652957
Operating income: -3988560.4113110537
Net income: -4552442.159383033
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1710.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 475000000 (Small Cap ($300M-$2B))
Debt to equity: 0.3936
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 247A.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 52868386816 (Large Cap ($10B-$200B))
P/E ratio: 0.18503333130861496
Debt to equity: 1.3252000000000002
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3484.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18104950784 (Large Cap ($10B-$200B))
P/E ratio: 0.08613293248677674
Debt to equity: 0.11019999999999999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3484.T (annual, report date 2026-03-31)
Altman Z-score: 2.9091442122486924 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 19.38524486672254%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.911240159491223%
Free cash flow margin: 6.825451735744689%
Revenue growth: 12.445887492073798%
Rule of 40 score: 19.271339227818487
Market cap: 18104950784 (Large Cap ($10B-$200B))
P/E ratio: 0.08613293248677674
Debt to equity: 0.11019999999999999
Free cash flow (dilution adjusted): 8545658.158158159
Operating income: 12771039.78978979
Net income: 8579204.204204204
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 4054.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7741371904 (Mid Cap ($2B-$10B))
P/E ratio: 0.12886291729773483
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 4125.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15272309760 (Large Cap ($10B-$200B))
P/E ratio: 0.08256463265328513
Debt to equity: 0.6286999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7509.T (annual, report date 2026-03-31)
Altman Z-score: 2.9696833014905764 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.869586261673145%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.36650557051977%
Free cash flow margin: 3.5217930915529814%
Revenue growth: 0.013064510904557352%
Rule of 40 score: 3.5348576024575387
Market cap: 6853097984 (Mid Cap ($2B-$10B))
P/E ratio: 0.02969012744461531
Debt to equity: 0.1868
Free cash flow (dilution adjusted): 8778459.70970971
Operating income: 11438838.838838838
Net income: 9019056.556556556
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 7509.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6853097984 (Mid Cap ($2B-$10B))
P/E ratio: 0.02969012744461531
Debt to equity: 0.1868
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8596.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 34113566720 (Large Cap ($10B-$200B))
P/E ratio: 0.04897201797184543
Debt to equity: 3.3806
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 9950.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10010784768 (Large Cap ($10B-$200B))
P/E ratio: 1.031991364835222
Debt to equity: 0.12480000000000001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ACDC.V (quarterly, report date 2026-01-31)
Altman Z-score: 114.32724451256374 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.647007169227976%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.645248108481979%
Rule of 40 score: 0
Market cap: 2594252 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -51112.59259259259
Operating income: -59430.370370370365
Net income: -59448.88888888888
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for AIZ (quarterly, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 10.832901841852207%
Capitalized R&D asset: 0
Free cash flow margin: 5.116809450016081%
Revenue growth: 2.0803486150907355%
Rule of 40 score: 7.197158065106817
Market cap: 13721722880 (Large Cap ($10B-$200B))
P/E ratio: 11.131794871794872
Debt to equity: 0.3761
Free cash flow (dilution adjusted): 175000000
Net income: 274100000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for AKBA (quarterly, report date 2026-03-31)
Altman Z-score: -5.615951261317579 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 37592680
ROCI (R&D adjusted): -3.840656572220051%
Rosenberg metric: -0.1438381867307115
Free cash flow margin: -46.572911997609445%
Revenue growth: -7.077158029919128%
Rule of 40 score: -53.65007002752857
Market cap: 327275072 (Small Cap ($300M-$2B))
Debt to equity: 7.2155
Free cash flow (dilution adjusted): -24937000
Operating income: -4696000
Net income: -9054000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for ALRIB.PA (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 218636256 (Micro Cap ($50M-$300M))
P/E ratio: 16.329411764705885
Debt to equity: 0.0637
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ALY.V (quarterly, report date 2025-09-30)
Altman Z-score: -7.084875769579528 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.854183147292275%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.283205552256846%
Free cash flow margin: -19.87987441416026%
Revenue growth: -19.667763786300725%
Rule of 40 score: -39.54763820046098
Market cap: 2433734 (Nano Cap (< $50M))
P/E ratio: 37.89767236327969
Debt to equity: 0.1217
Free cash flow (dilution adjusted): -6286.330935251799
Operating income: -145710.7913669065
Net income: 205333.09352517987
Long score: 2 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for AU1.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11868551 (Nano Cap (< $50M))
Debt to equity: 13.7606
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AU1.AX (annual, report date 2025-06-30)
Altman Z-score: -8.765547915120841 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1136.5296316070471%
Free cash flow margin: 129.73812694185528%
Revenue growth: -25.45313771813146%
Rule of 40 score: 104.28498922372383
Market cap: 11868551 (Nano Cap (< $50M))
Debt to equity: 13.7606
Free cash flow (dilution adjusted): 1910457.5163398692
Operating income: -69566013.07189542
Net income: -3553594.77124183
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for AVA (quarterly, report date 2026-03-31)
Altman Z-score: 0.6376359936337688 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.33247137052087183%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.7659462308908802%
Free cash flow margin: 4.56140350877193%
Revenue growth: 6.941838649155723%
Rule of 40 score: 11.503242157927652
Market cap: 3474946048 (Mid Cap ($2B-$10B))
P/E ratio: 15.863999999999999
Debt to equity: 1.1924
Free cash flow (dilution adjusted): 26000000
Operating income: 134000000
Net income: 92000000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CALC (quarterly, report date 2026-03-31)
Altman Z-score: -30.93642107932917 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -451.35869565217394%
Capitalized R&D asset: 6837520
ROCI (R&D adjusted): -55.331217582834%
Rule of 40 score: 0
Market cap: 12004923 (Nano Cap (< $50M))
P/E ratio: 0.42860413685691323
Debt to equity: -6.068840579710145
Free cash flow (dilution adjusted): -5417000
Operating income: -5611000
Net income: 4976000
Long score: 1 | Short score: 12
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CDL.L (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10436746 (Nano Cap (< $50M))
Debt to equity: -0.043687008487913605
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CMC.V (annual, report date 2026-04-30)
Altman Z-score: -192.00312529757377 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 293408.90183010686
Rule of 40 score: 0
Market cap: 14754827 (Nano Cap (< $50M))
Debt to equity: -0.762778744290161
Free cash flow (dilution adjusted): -2929189.05109489
Operating income: -1808181.02189781
Net income: -2977301.459854014
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for CMC.V (quarterly, report date 2026-04-30)
Altman Z-score: -188.10509550242926 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 364.2335766423357
Rule of 40 score: 0
Market cap: 14754827 (Nano Cap (< $50M))
Debt to equity: -0.762778744290161
Free cash flow (dilution adjusted): -992541.6058394159
Operating income: -641699.2700729927
Net income: -915872.9927007299
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for COUR (quarterly, report date 2026-03-31)
Altman Z-score: 1.9477415074334274 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -2.196704942586121%
Capitalized R&D asset: 63176000
ROCI (R&D adjusted): -3.6172158560490693%
Rosenberg metric: 0.054878048780487805
Free cash flow margin: -5.876341338783853%
Revenue growth: -0.6094464195022855%
Rule of 40 score: -6.485787758286138
Market cap: 1537745792 (Small Cap ($300M-$2B))
Debt to equity: 0.0076
Free cash flow (dilution adjusted): -11500000
Operating income: -25300000
Net income: -20500000
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for CRIS (quarterly, report date 2026-03-31)
Altman Z-score: -60.845606544507575 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -649.4228187919463%
Capitalized R&D asset: 12474310
ROCI (R&D adjusted): -41.58465541418946%
Rosenberg metric: -0.1953648068669528
Revenue growth: -100%
Rule of 40 score: -100
Market cap: 9530287 (Nano Cap (< $50M))
Debt to equity: 0.1052
Free cash flow (dilution adjusted): -9576000
Operating income: -11519000
Net income: -24199000
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for EDT.TO (quarterly, report date 2026-03-31)
Altman Z-score: -71.33158057261353 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -449.7194163860831%
Revenue growth: 129.89001468981883%
Rule of 40 score: -319.82940169626426
Market cap: 396115616 (Small Cap ($300M-$2B))
Debt to equity: -0.324553470495139
Free cash flow (dilution adjusted): -2882733.8129496407
Operating income: 51798.56115107914
Net income: -2113669.0647482015
Long score: 1 | Short score: 8
Recommendation: Short